Status:
UNKNOWN
Excimer Light for Alopecia Areata
Lead Sponsor:
University of British Columbia
Conditions:
Alopecia Areata
Eligibility:
All Genders
19+ years
Phase:
PHASE2
Brief Summary
Alopecia Areata (AA) is a chronic autoimmune inflammatory disease causing nonscarring hair loss. Many treatment modalities have been found to be helpful in AA, however, none on them cure the disease. ...
Detailed Description
Alopecia Areata (AA) is a chronic autoimmune inflammatory disease causing nonscarring hair loss. Many treatment modalities have been found to be helpful in AA, however, none on them cure the disease. ...
Eligibility Criteria
Inclusion
- Age \> 18 years.
- Subject has a patch of at least 12 cm2 on the scalp with no evidence of hair regrowth.
- Subject is willing and capable of cooperating to the extent and degree required by the protocol.
Exclusion
- Patients who received treatment for alopecia areata within the past 4 weeks.
- Patients with alopecia totalis or alopecia universalis.
- Patients with known photosensitivity like having polymorphous light eruption, connective tissue diseases, porphyria or Xeroderma pigmentosum.
- Pregnancy or breast-feeding.
- History of previous skin cancer.
- Patients that have participated in another investigational drug or device study within 30 days of enrollment.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01802177
Start Date
February 1 2013
Last Update
July 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Skin Care Center, Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 4E8